Authors


Alyssa Trenery, PharmD, MPH

Latest:

Hypoglycemia Upon Hospital Admission From Long-term Care: Health Care Resource Use

This analysis of a hospital billing database describes inpatient length of stay, intensive care unit length of stay, comorbidities, and costs for patients with diabetes after admission with hypoglycemia from long-term care or home.


David Pittman, BS

Latest:

Contributor: COVID-19’s Impact on ACO REACH Deserves CMS' Attention

CMS must account for inclusion of COVID years in 2023 ACO REACH benchmarks to avoid unfairly penalizing REACH ACOs.


Kenneth Cohen, MD

Latest:

Potential Spillover Effects on Traditional Medicare When Physicians Bear Medicare Advantage Risk

Medicare beneficiaries treated by physicians with high levels of Medicare Advantage risk exposure had higher care quality and efficiency outcomes compared with those treated by other physicians.


Dawn Wiest, PhD

Latest:

Dosage and Outcomes in a Complex Care Intervention

Associations between intervention dosage and hospital use outcomes were observed among patients enrolled in a care management program serving individuals with complex needs.


Edward Lee, PharmD

Latest:

Economic Burden of Joint Disease in Psoriasis: US Claims Analysis

This retrospective claims analysis found that concomitant joint disease in psoriasis is associated with greater health care resource utilization and health care costs than psoriasis alone.


Neda Khan, MHCI

Latest:

An Accelerated Hospital Observation Pathway to Reduce Length of Stay for Patients With COVID-19

For select patients hospitalized due to COVID-19, an academic urban hospital implemented an observation pathway that incorporated mobile health technology, reducing hospital length of stay by more than 2 days.


Arthur C. Jeng, MD

Latest:

Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net

This study evaluates the impact of Choosing Wisely–based interventions on antibiotic prescribing for viral respiratory tract infections in a real-world safety-net setting.


Ida Delmendo

Latest:

Strategies for Improving Transitions of Care for Patients With Diabetes: An Interview With Jennifer N. Clements, PharmD

Jennifer N. Clements, PharmD, is a clinical pharmacist in diabetes transition with Spartanburg Regional Healthcare System in Spartanburg, South Carolina. Clements is a board-certified pharmacotherapy specialist, board-certified ambulatory care pharmacist, and certified diabetes care and education specialist. She is currently developing a pharmacy service focused on the inpatient management of diabetes. An editor from The American Journal of Managed Care® recently conducted an interview with Clements to discuss strategies for improving transitions of care for patients with diabetes.


Sebastian Linnemayr, PhD

Latest:

Cost Savings From an mHealth Tool for Improving Medication Adherence

The Wellth smartphone app significantly increased medication adherence and lowered unnecessary health care utilization and costs over 9 months among Medicaid beneficiaries who were self-managing chronic conditions.


Susan Perlman, MD

Latest:

Friedreich Ataxia: Looking Forward at the Treatment Landscape

A Friedreich ataxia specialist shares their optimistic outlook on future developments in the management of the condition.


Jonathan A. Seward, MS

Latest:

Removing Medicare’s Outpatient Ban and Medicare and Private Surgical Trends

This article documents a 100% increase in privately insured outpatient knee replacement surgeries following Medicare’s decision to remove knee replacements from its Inpatient Only list.


Viviane Garth, BA

Latest:

Quality, Health, and Spending in Medicare Advantage and Traditional Medicare

In a review of literature published since the Affordable Care Act’s passage, more than half of analyses find that Medicare Advantage outperforms traditional Medicare on quality, health, and cost outcomes.


Gabriela Williams, PharmD, BCPS, BCPP

Latest:

Predicting Drug-Drug and Drug-Gene Interactions in a Community Pharmacy Population

The probability of drug interactions increases when genetic polymorphisms are considered, indicating that pharmacogenetic assessment may be useful in predicting the presence and severity of interactions.


Ronita Debnath, BSc

Latest:

Insurer Costs of COVID-19 by Disease Severity and Duration

Payer costs for COVID-19 ranged from a mean of $505 for asymptomatic cases to $126,094 for severe cases with post–COVID-19 condition.


James Henderson, PhD

Latest:

Agreement Among Measures Examining Low-Value Imaging for Low Back Pain

This study demonstrates the need for additional consensus surrounding how to translate guideline recommendations to administrative measures assessing imaging overuse for acute low back pain.


Courtney Dean, MBA

Latest:

Alternative Payment Models Can Stabilize and Improve Practice Radiation Reimbursement

How Value-based Care Is Changing Radiation Oncology for the Better


Lauren G. Gilstrap, MD, MPH

Latest:

Coverage With Evidence Development: Where Are We Now?

Review of CMS’ coverage with evidence development program exposes a need to improve program transparency and clarify requirements and timetables for reporting to improve access to novel therapies.


Kalpesh J. Desai, PharmD

Latest:

Pharmacists and Transitions of Care From Emergency Department to Home

Pharmacists’ roles in transitions of care continue to evolve. Evaluation of pharmacist-led interventions as patients transition from emergency department to home is needed.



Katie Everson, MS

Latest:

Two Steps Forward, One Step Back: 50 Years of Societal Value From LDL-C–Lowering Therapies

Low-density lipoprotein cholesterol (LDL-C)–lowering therapies have yielded significant value to society through reduced costs for both fatal and nonfatal cardiovascular disease events. The vast majority of this value has accrued to patients.


YuanYuan Michelle Cheng
YuanYuan Michelle Cheng

Latest:

Contributor: The Critical Role of Patient Engagement in Patient-Centered Outcomes Research and Health Technology Assessment of Rare Disease Treatments

Patient engagement is a necessity when performing health technology assessment to help better assess and identify the outcomes of a rare disease.


Carl Schmid

Latest:

Key Takeaways for the Management of HIV PrEP

A panel of experts share closing thoughts and advice for the management and uptake of HIV PrEP therapy.


Montara Renee November, MPA

Latest:

Integrating Mental Health Care Services Into HIV Comprehensive Care

Distinguishing between need and receipt of integrated services reveals that mental health care improves the likelihood of medication adherence among people living with HIV.


Rebecca A. Fletcher, PhD

Latest:

COVID-19 Vaccine Hesitancy and Health Literacy in US Southern States

COVID-19 vaccine hesitancy is not associated with health literacy. Personal perception of threat was associated with reduced vaccine hesitancy.


Sunali D. Goonesekera, MS

Latest:

Racial/Ethnic Differences in Autoimmune Disease Prevalence in US Claims/EHR Data

This analysis uses claims and electronic health records from 2021 to examine racial and ethnic variations in immune-mediated inflammatory diseases in the United States.



Yana Volman, MBA

Latest:

The Promise of Telehealth—a Cautionary Tale

Implications of Telehealth Use on the Future of Oncology Care


Christine Yee, PhD

Latest:

Veterans Health Administration Benefit Value Has Little Effect on Reliance

Relying on veteran survey responses and novel actuarial data, the authors examine the relationship between benefit value and reliance on the Veterans Health Administration.


Esteban A. Barreto, PhD, MA

Latest:

Addressing Virtual Care Disparities for Patients With Limited English Proficiency

With increased use of virtual care due to the COVID-19 pandemic, the following recommendations address disparities for patients with limited English proficiency.


Michael H. Huo, MD

Latest:

Standardized Total Knee Arthroplasty Pathway Improves Outcomes in Minority Patients

In a minority-predominant patient population, a standardized pathway for total knee arthroplasty was associated with improved outcomes with no change in postoperative complication rates.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo